logo
welcome
Time Magazine

Time Magazine

Is the Novavax COVID-19 Vaccine Better?

Time Magazine
Summary
Nutrition label

84% Informative

Novavax’s COVID-19 vaccine is not approved by the FDA yet, but it is available in the U.S. under emergency use authorization, which the FDA issued to the company in July 2022 .

The new mRNA vaccines from Moderna and Pfizer -BioNTech have dominated the vaccine story.

All COVID-19 vaccines from the three manufacturers have been linked to an increased risk of inflammation of heart muscle, or pericarditis or myocarditis.

People receiving the Novavax vaccine may be reporting fewer events such as fever, muscle aches, and headaches compared to those receiving either mRNA vaccine.